Most of studies showed that serum irisin levels were decreased in patients with type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), cardiovascular disease and metabolic bone disease,36, 37 as well as in infants born with neonatal respiratory distress syndrome (NRDS).38 This evidence concerns the gene FNDC5 and newborn respiratory distress syndrome.